Enochian Biosciences | Investor Presentation Deck | 39 slides · page 29 of 39
Mentions a specific cost range ($300k-$450k) as a pain point for current CAR-T therapies.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 3/3
list 1/1 paragraph 1/1 title 1/1
Components 3
bullet paragraph headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.